Finasteride vs Osimertinib

Finasteride vs Osimertinib: Overview

This comparison examines the pharmacological differences between Finasteride and Osimertinib.

Mechanism of Action

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Finasteride — 5-6 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Finasteride — C23H36N2O2; Osimertinib — C28H33N7O2.

Molecular Weight: Finasteride — 372.5490 g/mol; Osimertinib — 499.6050 g/mol.

Type: Finasteride — Small molecule; Osimertinib — Small molecule.